https://www.marketscreener.com/quote/stock/KIROMIC-BIOPHARMA-INC-113902312/news/Kiromic-Biopharma-Reports-Favorable-Early-Safety-and-Tolerability-Data-from-First-Patient-Enrolled-i-45681758/?utm_source=telegram&utm_medium=social&utm_campaign=share